| Sonny M Rothman, Hui Yin, Oriana H Y Yu, Michael Pollak, Laurent Azoulay. Incretin-Based Drugs and the Incidence of Endometrial Cancer Among People with Type 2 Diabetes: Active Comparator New-User Design. Drug Saf. 2025 May 10. PMID: 40347221. Online ahead of print. | download |
| Christopher Godina, Ann H Rosendahl, Kelin Gonçalves de Oliveira, Somayeh Khazaei, Sofie Björner, Karin Jirström, Karolin Isaksson, Michael N Pollak, Helena Jernström. Genetic determinants and clinical significance of circulating and tumor-specific levels of insulin-like growth factor binding protein 7 (IGFBP7) in a Swedish breast cancer cohort. Carcinogenesis. 2025 Apr 3;46(2):bgaf020. | download |
| Melissa C Orenduff, Carl F Pieper, Emma H Allott, Michael F Coleman, Su Yon Jung, Mara Z Vitolins, Jenifer I Fenton, Chu Chen, Candyce H Kroenke, Fred K Tabung, Ana Barac, Electra D Paskett, Michael N Pollak, Jennifer Hays-Grudo, Shine Chang, Stephen D Hursting. Plasma Insulin-Like Growth Factor Binding Protein-7 is Positively Associated with Age, Obesity, Mortality, and Cancer in Postmenopausal Women. Cancer Epidemiol Biomarkers Prev. 2025 Mar 28. Online ahead of print. | download |
| Allison C Sylvetsky, Ying Wang, Ananya G Reddy, Caroline Y Um, Rebecca A Hodge, Cari Lichtman, Diane Mitchell, Anuj Nanavati, Michael Pollak, *Ye Wang, Alpa V Patel, Marjorie L McCullough. Non-nutritive sweetener consumption, metabolic risk factors, and inflammatory biomarkers among adults in the Cancer Prevention Study-3 Diet Assessment Sub-Study. J Nutr. 2025 Mar 22:S0022-3166(25)00172-5. Online ahead of print. | download |
| Liang Chen, Sabrina Fallavollita, Lama Sakr, Hangjun Wang, Marc Pusztaszeri, Khashayar Esfahani, Michael N Pollak, Marie Hudson, Valérie Leclair. Case Series: The Challenge of Using Immune Checkpoint Inhibitors in Anti-Transcriptional Intermediary Factor 1γ Antibody-Positive Dermatomyositis. Int J Rheum Dis. 2025 Jan;28(1):e70087. | download |